The results of another meta-analysis revealed a considerably greater risk of all-grade bleeding, all-grade and high-grade hypertension as well as all-grade cardiac dysfunction in patients with tumours receiving VEGFR-TKIs [116]. The gene discussed is KDR; the disease is Hypertension.